Recent reports from the UK' 2 and USA3 have indicated a possible role for 1"'Indium leucocyte scintigraphy in the management of patients in exacerbation of chronic inflammatory bowel disease. The migration of labelled leucocytes to the areas of active inflammation enables scintigraphic estimation of the extent of the disease while its severity is related to the proportion of the leucocyte label which is shed in the faeces. This report describes the findings in our evaluation of the technique.
Methods

PATIENTS
Fifteen consecutive inpatients who were admitted in exacerbation of chronic inflammatory bowel disease were included in the study. Each gave informed consent to the intended investigation. Six patients had Crohn's disease and nine had ulcerative colitis diagnosed according to conventional critieria. SEVERITY Fig. 1 ). The scintigrams, however, underestimated the gross extent of disease in six instances (Fig. 2) .
In one patient (no 15) in whom there was a marked discrepancy between the scintigraphic and radiological findings subsequent colectomy showed no evidence of disease proximal to the sigmoid colon in spite of prior radiological evidence to the contrary.
Discussion
These results show that while the recovery of labelled leucocytes in the faeces reliably correlates with conventionally derived indices of disease activity in patients with 
